This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pacak K et al. (2001) Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134: 315–329
Lonser RR et al. (2003) von Hippel-Lindau disease. Lancet 361: 2059–2067
Brandi ML et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658–5671
Gutmann DH et al. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278: 51–57
Baysal BE (2003) On the association of succinate dehydrogenase mutations with hereditary paraganglioma. Trends Endocrinol Metab 14: 453–459
Neumann HP et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346: 1459–1466
Amar L et al. (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23: 8812–8818
Gimenez-Roqueplo AP et al. (2003) Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 63: 5615–5621
Neumann HP et al. (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292: 943–951
Harris M et al. (2005) Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol 6: 301–310
Acknowledgements
Several of the studies described in this paper were supported by grant AOM 02 068 from the Assistance Publique-Hôpitaux de Paris, Délégation à la Recherche Clinique for the COMETE (COrtico et MEdullo-surrenale: les Tumeurs Endocrines) network, and by the GIS-Institut des Maladies Rares for the PGL.NET network.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Plouin, PF., Gimenez-Roqueplo, AP. The genetic basis of pheochromocytoma: who to screen and how?. Nat Rev Endocrinol 2, 60–61 (2006). https://doi.org/10.1038/ncpendmet0097
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0097
This article is cited by
-
Sindromi feocromocitoma/paraganglioma familiari
L'Endocrinologo (2009)
-
Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation
Nature Clinical Practice Endocrinology & Metabolism (2008)
-
RENATEN : Réseau national de prise en charge des tumeurs (neuro-)endocrines malignes rares sporadiques et héréditaires
Oncologie (2008)
-
Pheochromocytomas and secreting paragangliomas
Orphanet Journal of Rare Diseases (2006)